Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, July 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Updates to Leading aCGH Data Analysis Software
Wednesday, March 26, 2014
OGT releases new CytoSure™ Interpret Software to enhance CNV detection.

Sapio Sciences Announces Exemplar NGS LIMS for Next Gen Sequencing Labs
Thursday, March 20, 2014
Exemplar NGS provides pre-built, clinical standard workflows for leading NGS platforms

Autoscribe Announces a New Concept in Screen Saving from Matrix Gemini LIMS
Thursday, March 20, 2014
New screen saving feature enables automatic audit trails.

Optibrium, Integrated Chemistry Design Collaborate on New iPad App
Monday, March 17, 2014
Asteris for iPad enables drug discovery scientists to quickly explore high quality compound ideas.

TATAA and MultiD Launch GenEx 6
Saturday, March 15, 2014
The software most compliant with guidelines for the analysis of real-time PCR data.

Schleicher Electronic Combines Hardware and Software Functions in Laser Machining
Saturday, March 15, 2014
Faster, more accurate, more efficient: “Position Synchronized Pulse”.

Dataworks Development's Biobank Management Software Gets Major Upgrade
Tuesday, March 11, 2014
Expanded configurability is most notable in the upgrade.

Accelrys Capture Drives Next-generation Mobility in the Laboratory
Tuesday, March 11, 2014
New mobile multi-media capture application lets scientists take laboratory data into their hands with accurate, real-time recording at the bench

Johnson Controls Launches Integrated Laboratory Services
Thursday, March 06, 2014
Company to optimize R&D facility operations and drive scientific productivity.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 841
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv